
A new therapy to re-engage the heart’s natural electrical pathways – instead of bypassing them – could mean more treatment options for heart failure patients who also suffer from electrical disturbances, such as arrhythmias, according to research led by the University of Chicago Medicine.
In a first-ever pilot study, called the His SYNC trial, researchers compared the effectiveness of two different cardiac resynchronization therapies, or treatments to correct irregularities in the heartbeat through implanted pacemakers and defibrillators. The current standard of care, known as biventricular pacing, uses two pacing impulses in both lower chambers, whereas the newer approach, called His bundle pacing, attempts to work toward engaging and restoring the heart’s natural physiology. The two approaches have never before been directly compared in a head-to-head clinical trial.
“This is the first prospective study in our field to compare outcomes between different ways to achieve cardiac resynchronization,” said cardiologist Roderick Tung, MD, FHRS, the Director of Cardiac Electrophysiology & EP Laboratories at the University of Chicago Medicine. “Through His bundle pacing, we’re trying to tap into the normal wiring of the heart and restore conduction the way nature intended. Previously, we have just accepted that we had to bypass it through pacing two ventricles at a time.”
Tung spearheaded the two-year trial with UChicago Medicine cardiologist Gaurav Upadhyay, MD, FHRS, lead author of the study. The trial involved 40 adult patients across seven institutions in the Midwest. The UChicago Medicine team served as the independent coordinating site. Results of the study were presented as a featured late-breaking trial at the Heart Rhythm Society’s annual scientific sessions in San Francisco on May 9. To qualify as a late-breaking trial, the research must be groundbreaking and unique. The study was also published in the Journal of the American College of Cardiology.
A different resynchronization method
Biventricular pacing involves implanting wires, called leads, to simultaneously pace the right and left ventricles of the heart. A pacemaker then sends a timed electric pulse to the two leads with the goal of a synchronized contraction, which closely simulates the heart’s natural heartbeat.
Nevertheless, roughly 30 percent of patients do not respond to biventricular pacing treatment, which has been shown to improve survival in clinical trials.
Tung’s team looked to see if another resynchronization method could help reduce that number by doing a clinical trial comparison between biventricular pacing and His bundle pacing. The latter involves implanting a single lead at the start of the heart’s wiring system, which then naturally branches in two to organically distribute the pacemaker’s electric pulse to both ventricles.
“Permanent His bundle pacing has been around for almost 20 years, but until now there hasn’t been randomized clinical trials on how it compares to biventricular pacing,” Tung said.
For the His SYNC trial, all of the patients met the current guidelines for receiving cardiac resynchronization therapy and were randomly selected to receive either a His bundle pacer or a coronary sinus lead for biventricular pacing. Patients weren’t told which treatment they received.
While the results of the preliminary study did not demonstrate superiority with His-CRT, Tung and his team believe a His bundle pacing approach showed comparable rates of response, warranting further study. The research was limited by a high crossover rate, which was required by the study’s protocol if an adequate lead placement could not be achieved. Nearly half of the patients selected to receive His bundle pacing had to eventually be treated with traditional biventricular pacing due to having a condition called interventricular conduction delay (IVCD). The implantation tools have also not been refined since their introduction 10 years ago.
“We need to learn how to better identify patients who cannot and will not respond to His bundle pacing,” Tung said. “During this pilot study, we learned that the net was cast too wide, and patients with IVCD can’t be corrected and improved by His bundle pacing. His SYNC II, our planned follow-up study, will specifically exclude these patients and this is perhaps the most valuable lesson from the pilot, in addition to estimated treatment effect size.”
In addition, 26 percent of patients chosen to receive biventricular pacing did not, usually because a lead could not be inserted due to the condition of their veins dictated by strict criteria to optimize implantation of left ventricular leads.
Comparing the two approaches
After six months, researchers compared the electrical synchronization and structural function of the two patient groups’ hearts. Although they expected His bundle pacing to be superior, they found no overall significant differences in the two groups, with comparable rates of electrical resynchronization and echocardiographic response.
After one year, there were no differences in the number of hospitalizations or deaths.
Noting the pilot study was limited by its size, Tung says the results indicate further investigation is needed.
“Pilot studies are never meant to be conclusive,” he said. “They’re meant to inform us about effect size, safety and feasibility to help select appropriate patients and power larger studies.”
Learn more: Treatment option to restore natural heartbeat could be on the horizon for heart failure patients
The Latest on: Heart failure
[google_news title=”” keyword=”heart failure” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Heart failure
- Increasing cardiac ketones may help heart failure in mouse studyon July 24, 2024 at 9:45 am
In mice with heart failure with preserved ejection fraction (HFpEF), increasing ketone supply to the heart allowed their hearts to utilize more ketones and produce more energy. Researchers hope this ...
- Doctor reveals 3 'lies' he taught in medical school about weight loss, heart diseaseon July 24, 2024 at 8:47 am
Dr. Robert Lufkin says he taught lies in medical school about weight loss, diet, high blood pressure, and statins to prevent heart disease. Experts respond.
- Treat Heart Failure More Like Canceron July 24, 2024 at 5:36 am
Heart failure should be handled more like cancer — with aggressive early treatment — targeting the cause of the disease, not just the symptoms.
- The link between heart failure and diabetes: what you need to knowon July 23, 2024 at 6:14 pm
Heart failure and diabetes are two serious health conditions that often occur together. Understanding the connection between these diseases can help improve treatment and prevention strategies. Here’s ...
- Cincinnati doctors among first in nation to implant new device to treat heart failureon July 23, 2024 at 9:34 am
Local doctors are among the first in the nation to use a new device to help patients in heart failure.The team at The Christ Hospital shared ...
- Heart Disease Newson July 22, 2024 at 5:00 pm
Researchers Elucidate Mechanism Behind Cardiac Fibrosis, Opening Way for New Heart Failure Treatments July 10, 2024 — Cardiovascular disease often culminates in heart failure, a hallmark of ...
- How Stress Can Increase Your Risk of Heart Diseaseon July 22, 2024 at 12:00 pm
Research suggests that chronic stress may be an important risk factor for heart disease. Here’s everything you need to know to keep your heart healthy.
- Heart disease in women: Understanding the onset of the disease, symptomsand risk factorson July 22, 2024 at 10:46 am
Various factors unique to women, such as premature menopause and gestational diabetes, contribute to the occurrence of coronary artery disease. Women often experience delays in seeking medical care ...
- Leading a healthier lifestyle can help offset genetic heart disease riskon July 22, 2024 at 10:00 am
New research suggests that lifestyle interventions could significantly mitigate even the highest genetic risk for cardiovascular conditions.
- Managing fluid retention in heart failureon July 19, 2024 at 2:17 am
Heart failure is a condition where the heart doesn’t pump blood as well as it should. One common problem for people with heart failure is fluid retention, which can cause swelling in the legs, ankles, ...
via Bing News